<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="recognize">
            <roleset id="recognize.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent&#x0A;" />
                    <role n="1" descr="thing being identified&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>A1 (the two forms of Stat3 (Stat3fm and Stat3sm) that can be recognized by anti-LMP-1 antisumption of affinity are the ones indicated.</text>
                    <arg n="0">anti-LMP-1 antisumption of affinity</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Blots were surveyed with a monoclonal antibody recognizing the STAT1 N-terminal.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminal</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>D1 antibody of anti-64kD human autoantigen is able to recognize a polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle, and smooth muscle in regulated promoters.</text>
                    <arg n="0">D1 antibody of anti-64kD human autoantigen</arg>
                    <arg n="1">a polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>D1 antibody of anti-64kD human autoantigen that has recognized a polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle, and smooth muscle was acquired from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">D1 antibody of anti-64kD human autoantigen</arg>
                    <arg n="1">a polypeptide approximately 70kD in the western muscles of the extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Individual cell clones were analyzed for the expression STAT1 by immunofluorescence, where polypeptide approximately 70kD in western areas of extraocular muscle, sternotirio muscle, and smooth muscle was recognized by anti-64kD antibodies of human autoantigen D1.</text>
                    <arg n="0">anti-64kD antibodies of human autoantigen D1</arg>
                    <arg n="1">polypeptide approximately 70kD in western areas of extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>NarL protein recognized heptameric in other arrangements in the regulated promoters.</text>
                    <arg n="0">NarL protein</arg>
                    <arg n="1">heptameric in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Paperprinting tests have suggested that these regulators protect a segment of up to 20 bp in target promoters, and various alignments of binding sites for a number of regulators have shown that the cAMP-CRP activator complex can recognize two sites in tsx-p2.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>STAT1 N-terminus will be recognized by the A monoclonal antibody.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>The epiptopes in the C-terminal of LMP-1 at a dilution 1:200 was recognized by the anti-LMP-1 antisembly purified acquired in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">anti-LMP-1 antisembly purified</arg>
                    <arg n="1">epiptopes in the C-terminal of LMP-1 at a dilution 1:200</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>The individual cell clones were analyzed for the expression of STAT1 by immunofluorescence, where multiple linkage site is recognized by most of the regulators belonging to the AraC/XylS family.</text>
                    <arg n="0">most of the regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple linkage site</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>activator complex cAMP-CRP are able to recognize two sites in tsx-p2 in regulated promoters.</text>
                    <arg n="0">activator complex cAMP-CRP</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>epiptopes in the C-terminal of LMP-1 at a dilution 1:200, was not recognized in the immunoprecipitaiton with anti-LMP-1 purified affinity antiserum as it was raised against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">anti-LMP-1 purified affinity antiserum</arg>
                    <arg n="1">epiptopes in the C-terminal of LMP-1 at a dilution 1:200</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>epiptopes in the C-terminal of LMP-1 at a dilution 1:200, will be recognized in the immunoprecipitaiton with anti-LMP-1 antisembly purified as it arises against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">anti-LMP-1 antisembly purified</arg>
                    <arg n="1">epiptopes in the C-terminal of LMP-1 at a dilution 1:200</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>heptamers in other arrangements were recognized by NarL protein.</text>
                    <arg n="0">NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>monoclonal antibody that recognizes STAT1 N-terminal is purchased in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">monoclonal antibody</arg>
                    <arg n="1">STAT1 N-terminal</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>most of the regulators belonging to the AraC/XylS family that recognizes multiple-link location is purchased from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">most of the regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple-link location</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>multiple-link location, cannot is recognized in immunoprecipitatio with most of the regulators belonging to the AraC/XylS family, as it is high against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">most of the regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple-link location</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>polypeptide approximately 70kD in western areas of extraocular muscle, sternotirio muscle, and smooth muscle has been recognized by anti-64kD antibodies of human autoantigen D1.</text>
                    <arg n="0">anti-64kD antibodies of human autoantigen D1</arg>
                    <arg n="1">polypeptide approximately 70kD in western areas of extraocular muscle, sternotirio muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>proteins also binds to these 727 sites but, unlike NarP, also recognized short reasons within the protected region.</text>
                    <arg n="0">proteins</arg>
                    <arg n="1">short reasons within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>the RNA ribosomal gene promoter are recognized by the upstream eukaryotic binding factor (UBF) with which the wires were probed.</text>
                    <arg n="0">the upstream eukaryotic binding factor (UBF)</arg>
                    <arg n="1">the RNA ribosomal gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>the promoter of the RNA ribosomal gene is recognized by A0 (monoclonal anti-HA RAT antibody (Boehringer-Ingelheim) with which the screws were sound.</text>
                    <arg n="1">the promoter of the RNA ribosomal gene</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A1 (the two forms of Stat3 (Stat3fm and Stat3sm) that were recognized by autological serum are the ones indicated.</text>
                    <arg n="0">autological serum</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Class I melanoma-specific T cells binds to these 727 sites but, unlike NarP, will also recognize a series of Ags.</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Footprint tests have suggested that these regulators protect a stretch of up to 20 bp in goal promoters, and multiple alignments of binding sites for a number of regulators have shown that the autological serum can recognize epiptopes.</text>
                    <arg n="0">the autological serum</arg>
                    <arg n="1">epiptopes</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>The blots were probed with autologous serum that can recognize A1 (epitopes in the C muscle of LMP-1 in a 1:200 dilution.</text>
                    <arg n="0">autologous serum</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>The individual cell clones were analyzed for STAT1 expression by immunofluorescence with Class and T cells specific to melanoma that recognizes a series of Ags and by western blotting.</text>
                    <arg n="0">Class and T cells specific to melanoma</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>These bands can be detected with Class I melanoma-specific T cells that recognized A1 (the different non-muscular myosin heavy chain isoforms (A and B)</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>We show that autologous serum will recognize the epitopes that are separated by 33 bp: a high-affinity site (CRP-1) overlaps the 35 bp region, and a low-affinity site (CRP-2) is centered in the 74 bp position.</text>
                    <arg n="0">autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>a number of Ags was recognized by Class I melanoma-specific T cells.</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a number of Ags</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>a series of Ags could be recognized in immunoprecipitatio with Class and T cells specific to melanoma, since it was elevated against a C-terminal region of Stat3 that lacks Stat3Beta.</text>
                    <arg n="0">Class and T cells specific to melanoma</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>a series of Ags is recognized by Class I melanoma-specific T cells by purchasing Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">Class I melanoma-specific T cells</arg>
                    <arg n="1">a series of Ags</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>epitopes are recognized by the autologous serum with which the wires were probed.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>epitopes, will be recognized in the immunoprecipitaiton with autologous serum as it arises against a C-terminal region of Stat3 that is missing at Stat3Beta.</text>
                    <arg n="0">autologous serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>one of the two monoclonal antibodies recognized A1 (epitopes in the C muscle of LMP-1 in dilution 1:200.</text>
                    <arg n="0">one of the two monoclonal antibodies</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>one of the two monoclonal antibodies recognizes COOH-terminal epitopes.</text>
                    <arg n="0">one of the two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>one of two monoclonal antibodies are able to recognize COOH-terminal epitopes in regulated promoters.</text>
                    <arg n="0">one of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>the RNA supply apparatus that recognizes the normal splice binding is purchased in transduction laboratories (Lexington, KY).</text>
                    <arg n="0">the RNA supply apparatus</arg>
                    <arg n="1">the normal splice binding</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>the autologous serum are able to recognize epitopes in regulated promoters.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>the autologous serum will recognize epitopes in regulated promoters.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">epitopes</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
